Podcasts about mrna

Pandemic Policies, Vaccines, and Harms to Children: pediatrician and author Dr. Elizabeth Mumper discusses her book “Kids and COVID: Costly Mistakes That Must Never Happen Again.” Mumper argues parents should question authorities, citing early pandemic decisions such as lockdowns, masking, and a “one size fits all” vaccine strategy despite children's low risk from COVID. She supports the Great Barrington Declaration's focus on protecting high-risk groups and criticizes suppression of repurposed treatments like hydroxychloroquine and ivermectin. The discussion raises concerns about mRNA vaccine safety, biodistribution of lipid nanoparticles, underreporting to VAERS, loss of long-term control groups, myocarditis risk in young males, and claims of severe neurologic effects and “turbo cancers.” Mumper describes developmental, educational, and mental-health harms from masking and school closures, challenges vaccine mandates as violating informed consent, explains the cell danger response concept, and criticizes Paxlovid while favoring integrative approaches.

Alabama11th Circuit court puts stay on execution that uses nitrogen hypoxia methodAG Marshall joins multi state coalition asking EPA to put mifepristone on list of  water contaminantsJohn Wahl wants to advocate for repeal of state income tax if elected as Lt.GovernorWes Allen and state lawmakers put out letter about the limits of the Lt. Governor's office in regards to taxesattack ads on Barry Moore's military records coming from PAC in AL have been pulled by WVTMFuneral arrangements have been made for Auburn University student who died in Japan while on vacation with familyNationalDOJ to take on states restricting the 2nd amendment with legal casesWI Senator Johnson says Covid vaccine needs ICD code to be treated as diseaseHog rancher says mRNA shots on pigs killed a fourth of themJournalist Lara Logan talks about the attack on US elections and culture by Globalist/Marxist/IslamistsPresident Trump calls of military strikes against Iran, says deal close to completion ( we will see about that !)

ASCO 2026 is a wrap, and we needed an extra week to digest it all! Here the review list: 1. RASolute 302 - daraxonrasib and its standing ovation 2. MajesTEC-9 - 2L teclistamab in multiple myeloma in patient population 100% exposed to CD-38 targeting drugs 3. Initsmeran autogene + pembrolizumab in resected melanoma. Only a Phase 2 study, but super promising and exciting use of personalized medicine using mRNA technology 4. Libretto-043 - adjuvant selpercatinib in RET-fusion positive NSCLC following resection and platinum-based chemotherapy (in most of these patients) 5. PROTEUS - meh 6. SARC041 - Phase study of abemaciclib vs. placebo in dedifferntiated liposarcoma. The placebo did very poorly 7. CROWN at 7-years continues to offer an enticing PFS plateau with lorlatinib use in advanced ALK rearrangement+ NSCLC The Learning Oncology Companion from KelleyCPharmD: https://www.kelleycpharmd.com/learning-oncology-companion-oncopharm

In this episode of SCW for Pharma, Evren Ozkaya welcomes Rajeev Kumar, Vice President at Biological E. Limited, a leading vaccine manufacturer and CDMO. Drawing on nearly three decades of experience across pharmaceutical manufacturing, supply chain management, and digital excellence, Rajeev shares his perspective on the evolution of the Indian pharmaceutical industry and the growing importance of quality, compliance, and digitalization.The conversation begins with Rajeev reflecting on how pharmaceutical manufacturing has changed since he entered the industry in the late 1990s. He explains that early pharmaceutical production focused heavily on antibiotics and APIs, where processes were comparatively straightforward and compliance requirements were less demanding. As the industry shifted toward vaccines, biologics, and other complex therapies, manufacturers faced significantly greater expectations around batch validation, data integrity, and audit readiness.Evren and Rajeev then explore the competitive advantages that have helped India become a global pharmaceutical powerhouse. While lower labor costs and large-scale manufacturing capabilities have historically contributed to India's success, Rajeev argues that the industry's strength today extends beyond cost leadership. He highlights India's growing expertise in producing complex biologics and vaccines at scale, supported by a highly skilled workforce and strong engineering capabilities.The discussion then turns to digital transformation and its role in improving productivity and reducing manufacturing costs. Rajeev explains that for advanced products such as mRNA vaccines and biologics, reproducible processes are essential. Monitoring yield, quality, and operational performance in real time requires digital technologies that support consistent execution and data-driven decision-making. He notes that while India continues to maintain cost advantages, future competitiveness will increasingly depend on talent, innovation, and manufacturing excellence.In the second half of the conversation, Rajeev provides a practical introduction to ALCOA+, one of the foundational frameworks for pharmaceutical data integrity. He explains the principles of Attributable, Legible, Contemporaneous, Original, and Accurate data, along with the additional requirements that data must be Complete, Consistent, Enduring, and Available. Rajeev demonstrates how technologies such as electronic batch records, digital logbooks, e-signatures, automated data collection, IoT connectivity, and cloud-based systems help manufacturers satisfy these requirements while improving operational efficiency.The discussion highlights an important connection between compliance and productivity. Rajeev explains that high-quality, automated data not only supports regulatory requirements but also enables better decision-making across manufacturing operations. As a result, investments in digital technologies often create benefits that extend far beyond compliance alone.Finally, Evren and Rajeev examine the future of digitalization in pharmaceutical manufacturing. While many companies still rely heavily on paper-based processes, Rajeev believes manufacturers must adopt digital transformation strategies that align with their level of digital maturity. Looking ahead, he suggests that as regulatory expectations continue to evolve, technologies such as digital logbooks and electronic batch records may become increasingly necessary—and potentially mandatory—for maintaining compliance and meeting future GMP requirements.Evren and Rajeev conclude their insightful conversation by emphasizing that quality, compliance, and digital transformation are becoming inseparable. As pharmaceutical manufacturing continues to advance toward more complex therapies, organizations that combine strong data integrity practices with modern digital technologies will be best positioned to achieve both regulatory excellence and operational performance.

This episode unpacks how a major Ebola outbreak in Central Africa exposed critical gaps in global health surveillance and assesses U.S. preparedness for future biological threats.   Host: James M. Lindsay, Mary and David Boies Distinguished Senior Fellow in U.S. Foreign Policy, CFR   Guest: Thomas J. Bollyky, Bloomberg Chair in Global Health; Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program   We Discuss:   The current state of the Ebola outbreak in the DRC and Uganda, and why the case count was already high by the time authorities reported it. Why governments are often slow to report cases during outbreaks, and what delayed reporting may have cost in this instance. Why the WHO has discouraged trade and travel restrictions. How the U.S. withdrawal from the WHO is shaping a more limited response. Whether China is stepping in to fill the global health leadership gap left by U.S. institutional withdrawal. What the politicization of mRNA vaccine technology means for the U.S. ability to respond to future outbreaks that require rapid vaccine deployment. How artificial intelligence creates opportunities to accelerate global health responses, but also introduces new risks like engineered pathogens.   Mentioned on the Episode:   CDC Health Alert: Ebola Disease Outbreak in the DRC and Uganda, May 19, 2026   WHO Disease Outbreak News: Ebola caused by Bundibugyo Virus, DRC and Uganda, May 21, 2026   WHO Declaration of Public Health Emergency of International Concern, May 17, 2026   Bollyky et al., "Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis," The Lancet   CDC Mobilizes International Response Following Ebola Disease Outbreak, May 18, 2026   For an episode transcript and show notes, visit The President's Inbox at: https://www.cfr.org/podcasts/presidents-inbox/americas-ebola-preparedness   Opinions expressed on The President's Inbox are solely those of the host or guests, not of CFR, which takes no institutional positions on matters of policy.

In the world of leaders who have investigated and informed citizens everywhere about the malevolent intentions behind the COVID pandemic, one of the most effective has been lawyer Reiner Fuellmich, who continues to be silenced and imprisoned in Germany after one of the most bizarre and abusive “trials” ever to occur in a modern courtroom in the Western World.  The German administration should be genuinely ashamed for exposing themselves as puppets of the Globalist cabal who are silencing dissenters who revealed the true nature of the COVID policies and practices. Reiner Fuellmich began his professional career with a doctorate in law. His first focus was on medical and pharmaceutical law at the University of Gottingen, where he worked as a research assistant. This background would prove invaluable when he began in 2020 to investigate and expose the COVID conspiracy and the hidden hands of the elite internationalists manipulating the shuttering of national economies and installing control of whole populations. As a consumer protection and trial lawyer in Germany and in California, Reiner opened his own law firm in 1993. He may have been best known for his successful work in representing consumers who were sold Volkswagen vehicles with defective emissions devices. His background included consumer law related to international banks, including Deutsche Bank, and investor protection suits representing victims of “junk real estate” investments. But Dr. Reiner Fuellmich was just getting started in his advocacy. As with so many others in the “new freedom leadership,” Reiner and his wife recognized the authoritarianism embedded in the early 2020 COVID pandemic lockdowns, other mandates, and sudden legal declarations. People were ordered to stay home; no public gatherings were allowed; masks were required when going out; and all small businesses were closed, except for a few. Children were ordered to stay home from school to “learn remotely.” All these interventions, along with their draconian enforcement by law enforcement, were a red flag. So he and his wife left California and returned to their home country, Germany, where he could gather more information. The Corona Investigative Committee was the immediate result of Reiner's return. Over the next 2 years or so, Reiner and colleagues conducted approximately 400 interviews with physicians, scientists, medical specialists, economists, historians, investigative journalists, and others seeking answers to the unprecedented shutdown of the world. Reiner was the primary member of the task force, and Dr. Breggin was one of his key witnesses. The Corona Investigative Committee was so successful that it was an enormous threat to the globalist overlords. The committee members saw other groups and individuals around the world having bank accounts seized or frozen, including the fundraising account for the COVID-19 protesting Truckers in Canada. They agreed with legal documents to disperse the funds within the leadership to be held securely until such time as the threat of seizure was passed. In 2022, Reiner traveled to the US to participate in a speaking tour titled “Crimes Against Humanity,” and while he was out of the country, the other primary member of the committee removed Reiner from the group. There was a general “disruption” among the four members of the original investigative committee (which we have seen happen often when an organization begins to have an impact) Reiner was forced to go to and remain in the US and then Mexico, where he began another investigative committee: the International Crimes Investigative Committee. Reiner's first formal interview for the new committee was conducted with expert journalist Naomi Wolf, psychiatrist Peter Breggin, and Prof. Dr. Sucharit Bhakdi and his wife Prof. Dr. Karina Reiss. That seminal first interview explored the vital issue of “stunning personality changes” caused by mRNA covid vaccines. Despite everything, Dr. Fuellmich was undeterred in his international investigation of the globalists and the United Nations/World Health Organization/World Economic Forum efforts to capture control of the free world. Germany brought criminal charges against Dr. Fuellmich for taking the protective measures that had been taken to protect CIC funds. Dr. Fuellmich was accused of embezzlement. Reiner was marooned in Mexico after being denied visa entry again into the United States. His passport disappeared, and when he went to the German embassy in Mexico to collect a new passport, he was captured, held, and transported back to Germany. Arrested by German authorities, Dr. Fuellmich was transported to the maximum-security prison in Rosdorf. He has remained incarcerated by German authorities to this day. Dr. Fuellmich directly addressed the various rumors and whispers about his legal case on March 10, 2026, in his “Press Release – ICIC. law—The History of Dr. Reiner Fuellmich's Kidnapping.” Dr. Reiner Fuellmich declared: Here I have once again put together the story of my kidnapping from Mexico in the context that is relevant from my point of view, so that anyone who has already heard a little about the case – “embezzlement, he screwed everyone over, but somehow something is really fishy” – can immediately see that this is certainly not a criminal case being pursued, but rather a political case that has been fabricated. The Fuellmich trial was a mockery, bleeding on for over a year, before and during which Reiner was subjected to shocking neglect and abuse within prison. The outcry about the false imprisonment, massive trial manipulations, and human rights violations committed while holding Dr. Fuellmich before and after trial are covered in detail by our guest this week, Seba Terribilini. She is a Swiss activist. She has followed Reiner's work, dedicated the past two and a half years to attending the entire trial proceedings, and is now trying to raise awareness of him. She has also visited him three times in prison. Film director and investigative journalist Philippe Carillo, along with Seba Terribilini, is currently working on a documentary about Reiner's persecution. The trailer for the Free Reiner film is here. We greatly admire and heartily support Reiner Fuellmich as well as Seba Terribilini for her efforts to increase public awareness of Dr. Fuellmich's plight and his need for justice. May God bless both Fuellmich and Terribilini. ______   Learn more about Dr. Peter Breggin's work: https://breggin.com/   See more from Dr. Breggin's long history of being a reformer in psychiatry: https://breggin.com/Psychiatry-as-an-Instrument-of-Social-and-Political-Control   Psychiatric Drug Withdrawal, the how-to manual @ https://breggin.com/a-guide-for-prescribers-therapists-patients-and-their-families/   Get a copy of Dr. Breggin's latest book: WHO ARE THE “THEY” - THESE GLOBAL PREDATORS? WHAT ARE THEIR MOTIVES AND THEIR PLANS FOR US? HOW CAN WE DEFEND AGAINST THEM? Covid-19 and the Global Predators: We are the Prey Get a copy: https://www.wearetheprey.com/   “No other book so comprehensively covers the details of COVID-19 criminal conduct as well as its origins in a network of global predators seeking wealth and power at the expense of human freedom and prosperity, under cover of false public health policies.”   ~ Robert F Kennedy, Jr Author of #1 bestseller The Real Anthony Fauci and Founder, Chairman and Chief Legal Counsel for Children's Health Defense.  

In 2011, Stéphane Bancel walked away from the security of leading a 6,000-person diagnostics company to join a startup of about 50 people, built on an idea most scientists had dismissed: that messenger RNA could become medicine. Almost everyone told him not to do it. He gave the bet roughly a five percent chance. Nine years later, that same bet helped the world face a pandemic in 63 days.Stéphane Bancel is the Chief Executive Officer of Moderna. Under his leadership the company designed a COVID-19 vaccine on a computer within days of the genetic sequence being posted, delivered the first dose to a human just 63 days later, and scaled from zero manufacturing to a billion doses in twelve months. Today Moderna is building personalized cancer vaccines and using AI to reinvent how medicines are discovered and made.This conversation sits right at the heart of what I believe about leadership. That the chief executive is really the chief energy officer. That the boldest decisions are rarely about appetite for risk, they are about the asymmetry between what you could give the world and what you could actually lose. Stéphane lives both, and he is refreshingly honest about the storms, the doubts and the mistakes along the way.In our conversation, we explore: → The five percent bet: how he weighed an enormous upside against a manageable downside, and why his wife was the only one who said yes → What sailing without GPS taught him about staying calm when the storm hits, and why a storm always passes → The 63-day sprint, and the Sunday phone call that saved the manufacturing of a billion doses → Why he slowed a trial down so it would be a vaccine for the world, not a vaccine for white people → The future he sees: personalized cancer vaccines, the human body mapped in silico, and why he calls chemotherapy tomorrow's barbaric history“I still believe that we have not invented yet our best drug.” Stéphane Bancel, CEO of ModernaIf you have ever faced a decision that everyone around you called too risky, this one is about how to think, and how to stay calm, when you choose to leap anyway.

Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/10-06-2026Nesta quarta-feira, o boletim destaca avanços históricos na imunoterapia oncológica, novas fronteiras para os análogos de GLP-1 e o futuro digital da saúde pública. Iniciamos com os dados consolidados da ASCO sobre as vacinas personalizadas de mRNA, que demonstraram benefícios duradouros contra o melanoma e resultados muito promissores em tumores complexos de pâncreas e glioblastoma. Analisamos também a evidência de que os agonistas de GLP-1 atuam na redução da inflamação sistémica e cutânea da psoríase. No Radar, detalhamos como a Copa do Mundo de 2026 servirá de laboratório para uma vigilância epidemiológica preditiva, monitorizando desde águas residuais até redes sociais para prever surtos de doenças como sarampo e ebola.Afya News. Informação médica confiável e atualizada no seu tempo.

Episode SummaryIn the Season 2 finale of Breathless, host Jeremie Saunders tackles the ultimate question facing the Cystic Fibrosis (CF) community: Are we finally on the verge of a true cure? Growing up sick, Jeremie developed a psychological "immunity" to the repetitive promise that a cure was "just around the corner." But today, the conversation is fundamentally different.This episode takes us out of the pharmacy and directly into the laboratories where researchers are transitioning from small-molecule symptom management to structural gene editing. Featuring Dr. Bowen Li (University of Toronto), Dr. Paul Eckford (Chief Scientific Officer, CF Canada), and Kelly Grover (CEO, CF Canada), we pull back the curtain on the grueling reality of scientific research—described as "pushing a boulder up a hill with chopsticks." We explore how the global proof of concept from COVID-19 mRNA vaccines has turbocharged CF research, how CRISPR molecular scissors are being engineered to permanently rewrite genetic typos, and how Machine Learning is drastically accelerating the timeline to reach the final 10% of the community.Main Topics & Key Moments1. The Cost of Hope & The Ground ShiftThe Practiced Optimism: Jeremie details the emotional exhaustion of childhood hope cycles, where promised breakthroughs consistently failed to materialize, leading to a defensive "self-preservation" mindset in his twenties.A New Vocabulary: Why current scientific progress is materially different. For the first time, data-driven researchers are using definitive terms like functional cure, mutation-agnostic, and restoring normal function at the source.2. The Grind of the ArchitectureChopsticking the Boulder: Dr. Bowen Li describes the quiet, unglamorous reality of the lab at 8:00 PM on a Tuesday, where progress is measured in microscopic, hard-won inches.The Lazarus Effect vs. The Temped Joy: CEO Kelly Grover recalls an early advocacy trip to Ottawa with a profoundly ill young man, contrasting his miraculous post-Trikafta transformation with the sobering reality of meeting patients who remain devastatingly sick.3. The Molecular Typo: Nonsense MutationsThe Broken Text: While Trikafta acts as a structural prop for a wobbly, misfolded protein, it is entirely useless for patients with "nonsense mutations."The Cellular Stop Sign: Dr. Bowen Li explains that in these rare variations (such as the W57X mutation discussed in previous episodes), the cell hits a premature stop sign in the middle of reading the genetic sentence. The protein is cut off too early and never forms, leaving nothing for modulator drugs to attach to.4. Photocopies and Vaults: mRNA vs. CRISPRThe Vault Analogy: Dr. Li frames human genetics simply: DNA is the master cookbook safely locked inside the nucleus vault. You cannot remove the book, but you can create a temporary photocopy of a single page to take to the kitchen. That photocopy is mRNA.The Platform Revolution: A historical look at mRNA, from its discovery by Brenner and Crick in the 1960s to Katalin Karikó's underfunded, decades-long battle to chemically stabilize the molecule. The global deployment of COVID-19 vaccines served as the ultimate medical proof of concept, opening the floodgates for respiratory disease mapping.The Lipid Nanoparticle Trojan Horse: To get delicate mRNA past the lung's natural "bouncers" (mucus and cilia), scientists wrap it in a micro-engineered fat bubble designed to slide through sticky blockages and hit targeted cells.CRISPR Molecular Scissors: Moving beyond temporary photocopies, CRISPR edits the master cookbook itself. Hijacked from a bacterial immune defense system discovered in yogurt cultures, Jennifer Doudna and Emmanuelle Charpentier engineered the Cas9 protein to act as scissors guided by genetic GPS. Modern iterations—like base editing and prime editing—can cleanly correct a single letter in the double helix without fracturing the strand. Hosted on Acast. See acast.com/privacy for more information.

If you are worried about China taking over due to having better robots than the yanks, I got mixed messages for ya here. This was created using DeepSeek v4 Pro. Remember when DeepSeek could do the same thing as chatGPT but on shitty processors and not much RAM? All those stocks shit themselves? Oh what memories. Would have been a great time to buy NVIDIA stocks. I didn't, if you're asking....It's pretty good but it really didn't follow the instruction in the prompt that Joel Hill is Jack the Insider on the transcript. So that's a minus point. But also, this took fucking ages to generate. It's better than lots of the yankee slop but damn son this took MINUTES. So they might take over if we are patient or whatever. Enjoy the episode. ----------------------------------------------Joel Hill (Jack the Insider) and Hong Kong Jack return for a sprawling episode that tackles two of the biggest stories shaping politics in 2026. The pair open with the jaw-dropping Redbridge poll putting One Nation at 31% of the primary vote — a number that would all but wipe the National Party off the federal map and potentially deliver Anthony Albanese a strengthened majority government by splintering the right. Joel and Jack clash over whether culture-war grievances or material concerns are driving the surge, while drawing historical parallels to Joh for Canberra and the DLP split of the 1950s.The conversation then crosses hemispheres for a tour through UK chaos: Peter Mandelson's leaked dossier exposing a rudderless No. 10 under Keir Starmer, Nicola Sturgeon's estranged husband pleading guilty to embezzling SNP donations on a surreal shopping spree of Lalique salt shakers, seven Dysons, and a motorhome with four miles on the clock, and a deeply troubling police body-cam incident that has reignited the two-tier policing debate ahead of three critical by-elections.The centrepiece of the episode is a sober, hour-long deep dive into the COVID-19 pandemic and what Australia has refused to learn. The Two Jacks lay out the true death toll (perhaps 22 to 69 million globally), the devastating scale of long COVID, the vaccine rollout failures, the absurdities of hotel quarantine with rubbish bags over heads, and why governments and public health officials are desperate to avoid a Royal Commission. They close by asking whether the next pandemic will meet a population that has permanently lost trust in its leaders — and whether we'll simply repeat the mistakes of both COVID and the Spanish flu.Sport provides a lighter coda: the Carlton revival under an interim coach, James Hird's awkward candidacy at Essendon, the expanded 48-team World Cup that nobody seems excited about, and a formidable New Zealand Test side taking on England at Lord's.00:00:25 — Introduction Joel welcomes listeners to Episode 159, recorded 4 June. Today: Australian political news, a check-in on the UK, and a deep dive into the COVID-19 pandemic.00:01:21 — The Redbridge Poll: One Nation at 31% The AFR's Redbridge poll: One Nation 31%, Labor 28%, LNP 20%, Greens 12%. The two-party preferred is now being calculated as One Nation versus Labor — a seismic shift in how Australian politics is measured.00:03:12 — Not Just a Protest Vote Jack argues this is real, not a re-run of Hanson's 1990s flash-in-the-pan. The South Australian state election and the Farrah by-election suggest One Nation support is durable. Joel counters that protest votes can be expressed at the ballot box and that Australians are tiring of pluralism.00:04:09 — If One Nation Succeeds, Labor Wins The cruel irony: One Nation's rise probably delivers Labor government. The National Party could simply disappear. The DLP kept the Coalition in power for decades as an anti-Labor party; One Nation may do the reverse.00:05:46 — Scrutiny and Splintering Joel notes One Nation's policies are "two-sentence fragments" and motherhood statements. When proper scrutiny arrives, the contradictions will surface. Hanson's parliamentary attendance is as poor as imaginable.00:08:22 — The Third Rail Jack argues populists succeed because they discuss what polite society won't: immigration, culture wars, welcome to country rituals. The major parties must engage these topics or cede the ground entirely.00:11:34 — Feeling Unheard The core driver, Jack contends: voters feel sneered at and silenced by mainstream politics. It's not about flag counts, it's about being listened to.00:13:50 — What Actually Drives Votes Joel pushes back: voting determinants are the household economy, migration, climate change — not culture war trivia. Culture wars "don't amount to a hill of beans" at the ballot box.00:14:51 — The DLP Parallel Both agree the One Nation phenomenon most closely resembles the DLP split of the 1950s and 60s — a right-wing fracture that delivered Labor government after Labor government.00:17:18 — The Republic Referendum Lesson Jack recalls the 1999 republic referendum: pro-republicans split between models rather than uniting, scuppering the whole project. Voters will vote their preference even knowing it helps their enemy.00:19:32 — UK Parallels: Accommodate or Fight? Significant figures in the UK Tory party are debating whether to fight Reform or reach an accommodation. Tony Abbott recently said the Liberal Party won't criticise Pauline Hanson.00:21:48 — Joh for Canberra Redux Imre Salusinszky's comparison: this is "Joh for Canberra" all over again. But Joel notes Joh's moment lasted months; One Nation's has already lasted years.00:24:08 — State Election Previews Joel predicts the Victorian state election will be chaotic and peculiar — a government that's been in power too long, an opposition that may not be up to the task, and One Nation peeling votes from safe Labor seats. NSW will give a clearer reading.00:25:44 — Hanson "Ready to Govern" — from the Senate? Pauline Hanson announced she's ready to govern. Joel asks: shouldn't she contest a lower-house seat first? Jack recalls the only precedent: John Gorton became PM while still a senator, but had to be eased into Kooyong.00:28:20 — The Mandelson Dossier: Starmer's Empty Suit Jack's read of the leaked Mandelson documents: ministers don't know what the PM wants, there's zero respect or fear of his authority. Starmer comes across as an empty chair. One minister's text: "Every meeting with Labour MPs — it's all about who can we tax to pay benefits to other people."00:30:50 — Mandelson's Legal Peril Mandelson is under police investigation for misconduct in public office. Could face charges — the seriousness depends on whether it's mere misconduct or genuine bribery for foreign interests.00:31:49 — The Nicola Sturgeon Saga Her estranged husband has pleaded guilty to embezzling roughly £400,000 in SNP donations. The shopping list: six high-end coffee machines, seven Dyson vacuums, Lalique salt and pepper shakers, Montblanc pens, Swiss watches, an iJag, part of a Volkswagen, and a motorhome with four miles on the clock parked at his 92-year-old mother's house. Nicola claims she "didn't go in the kitchen much."00:34:20 — The BBC Interview Laura Kuenssberg's forensic interview with Sturgeon — "not quite Prince Andrew, but not much better." Sturgeon has been cleared by Police Scotland, but her reputation, already damaged by the Alex Salmond trial, is now in tatters.00:35:05 — Will He Go to Prison? £400,000 is a substantial sum. With another £600,000 unaccounted for, a custodial sentence seems likely. The money was ring-fenced for a second independence referendum push.00:36:50 — Money Laundering or Conspicuous Consumption? Joel wonders if the bizarre purchases — multiple watches on the same day — were an amateur money-laundering attempt: buy goods with SNP funds, sell them quietly for cash.00:38:23 — UK By-elections: Makerfield Looms Three by-elections on 18 June, including the critical Makerfield contest. Andy Burnham, Greater Manchester's high-profile mayor, is the tepid favourite. Low turnout could help him return to Westminster.00:39:30 — The Body-Cam Incident A white teenager accused of racially vilifying a Sikh man was stabbed — and police arrested the bleeding victim, not the attacker. Body-cam footage shows the victim saying "I can't breathe, I've been stabbed" while officers dismiss him. Joel calls the footage "just awful."00:41:22 — Two-Tier Policing Jack traces UK policing's overcorrection: after the Macpherson/Lawrence report, guidelines were rewritten so aggressively that they've produced a pattern of questionable enforcement that devastates community trust — and plays directly into Tommy Robinson's hands.00:42:08 — NSW Police on Four Corners Joel recommends the harrowing Four Corners investigation: bashings in custody, false arrests, an officer who threw body-cam footage into Sydney Harbour, and two undercover officers jailed for a savage assault. The problem today is general duties policing, not the specialist squads of the 1980s. Some command areas are far worse than others — a leadership failure.00:44:55 — Victoria Police: Under-Resourced, Not Corrupt Joel shares an anecdote: two divisional vans for 80,000 people in outer-east Melbourne. Tough work being a police officer; even tougher being a good one.The COVID-19 Reckoning00:45:09 — Why This Matters Joel sets the frame: we parked COVID in 2023 with a hangover but never understood what we'd been through. Today's episode aims to crack that problem.00:45:51 — The True Death Toll Officially: 7 million dead. But most countries stopped testing and stopped reporting cause-of-death data to the WHO. Using excess mortality, the real toll is between 22 and 69 million — at the high end, exceeding the Spanish flu.00:47:02 — Long COVID's Shadow Roughly 400 million people globally (6% of the population) have experienced long COVID. In Australia alone, between 200,000 and 500,000 people are living with or have lived with the condition. Second infections can be worse. Emerging links to cardiovascular disease, type 2 diabetes, and accelerated dementia.00:49:43 — The Collective Amnesia Governments worldwide have "a collective embarrassment" about how they handled the pandemic, Jack says. They want it in the history books and forgotten. Joel says this is a grave mistake for public trust — and for public health, given COVID is now a permanent fixture alongside flu season.00:50:50 — Why Excess Deaths Are the Only Honest Metric All other figures are "kind of made up" because attribution methods vary wildly between countries. Excess deaths remain elevated in Australia and most nations.00:51:25 — Children and COVID Bobby Kennedy Jr. removed under-18s from government-supported vaccines in the US. Joel argues this is a disastrous move given mounting evidence that childhood COVID infection leads to higher rates of long-term chronic illness.00:52:47 — Why No Royal Commission? Not just politicians protecting themselves — public health officials and much of the media wanted to avoid scrutiny of their judgments and actions during the pandemic.00:53:32 — The Media's Abdication Jack watched "a lot" of Daniel Andrews's daily press conferences. Only two journalists ever asked pertinent questions: Rachel Baxendale and Leigh Sales. Nobody asked why curfews, why beach arrests, why the disparate impact on tradies and cafe owners while the "laptop class" actually made money working from home.00:56:14 — Andrews's Immense Popularity Joel adds context: Andrews was wildly popular at the time, which partly explains the media's deference — though Jack insists that shouldn't have mattered.00:57:34 — The Curfew Nonsense Curfews were about giving law enforcement the easiest possible environment, Joel says — and should have been acknowledged as such and wound back sooner. Meanwhile, Bondi's wealthy swam en masse while Western Sydney's working-class communities were treated harshly.00:57:59 — The Vaccine Rollout Failure The Morrison government bet everything on AstraZeneca — the non-mRNA, first-available vaccine. Then rare blood-clotting issues emerged (seven deaths, mainly men aged 40–49). Meanwhile, Australia was left waiting for Pfizer and other mRNA vaccines because no other supply deals had been secured.00:59:37 — Omicron Breaks the Pandemic's Back The Omicron variant emerged from South Africa: more infectious but far less lethal. Combined with 95%+ vaccination rates among Australians over 18, it effectively ended the acute phase — though at the cost of entrenched mistrust.01:00:38 — Government Overreach and Broken Trust Jack's core criticism: governments outsourced decision-making to public health officials rather than making political judgments that balanced competing interests. Joel counters that it would have been a "bold move" for politicians with no scientific background to contradict public health advice.01:02:19 — "Just Let It Rip" Was Never an Option The three countries with the highest COVID mortality — Brazil (highest), United States (second), India (third) — were all led by populist governments that largely refused mandates. Letting it rip was devastating.01:03:27 — The ADF Quarantine Scandal Scott Morrison refused to allow ADF quarantine facilities to be used for returning travellers. Instead, people were crammed into hotels with gaps under the doors. Joel recalls the "rubbish bags over heads" episode in Victoria — dark green plastic bags as infection control.01:05:00 — The Inquiry's Recommendations Create a proper Australian CDC. Release expert advice publicly. Better national planning with clear political accountability. And critically: politicians must own the big decisions on freedoms and spending instead of hiding behind experts.01:06:01 — The Next Pandemic There will be another one. If it's a respiratory, airborne pathogen like COVID, similar circumstances will return. Are we ready? Probably not. Will we close the country again? The economic damage — unemployment hitting 7.5% in 2020 — was enormous, even if it recovered to 3.5% by pandemic's end.01:08:06 — Who Was Left Behind? The arts community was inexplicably excluded from JobSeeker and JobKeeper. Meanwhile, the "laptop class" working from home effectively got a 15% pay rise by eliminating commuting costs. Bunnings did very well; so did companies that kept JobKeeper without passing it to employees.01:11:14 — The Human Cost of Lockdowns Public housing towers in Flemington were locked down. Joel recalls one family: an African-Australian single mother with nine children in a two-bedroom commission flat, trapped. Jack calls what happened with schools "disgraceful." But Joel notes the evidence now shows childhood COVID infection has serious long-term health consequences, complicating the retrospective judgment.01:13:59 — Will We Learn Anything? Jack's bleak prediction: the next pandemic is probably far enough away that we'll take no notice of COVID's lessons and make the same mistakes. Joel agrees — we didn't learn from the Spanish flu a century ago either.01:15:51 — Malcolm Roberts and Vaccine Misinformation The One Nation senator claims 70,000 Australians died from COVID vaccines — a figure with no evidentiary support, built by misattributing excess deaths. In reality, mRNA technology is now being deployed as a cancer treatment, showing promise against bowel and pancreatic cancers.01:17:36 — Trust Destroyed If the next pandemic arrives within this generation, governments will face a population that has lost faith. If it takes 50 years, the damage may have faded. Western Australia, meanwhile, locked itself down with negligible deaths and actually loved the isolation — provided the iron ore and LNG ships kept moving.01:20:37 — The Spanish Flu Echo Joel's closing historical note: Australia's response to the Spanish flu in 1919–1921 was nearly identical to COVID — lockdown disputes, police arresting people for not wearing masks, states fighting the newly created federal Department of Health. The whole thing collapsed into acrimony the moment state rivalries flared. A century later, nothing had changed.01:21:48 — Federation as Fatal Flaw Jack adds: the three high-mortality COVID countries (US, Brazil, India) share a feature beyond populist leaders — they're all federations where central government power is limited. When "the emperor is far away and the mountains are high," coordinated pandemic response is nearly impossible.01:23:40 — No Appetite for Truth Jack's final word: nobody wants a proper inquiry. Not politicians, not public health officials, not much of the media. Joel disagrees on the importance — the pandemic's legacy still shapes how Australians think, vote, and trust.Sport01:27:40 — AFL Coaching Carousel Essendon and Carlton both need permanent coaches. Joel asks: is James Hird the right man for Essendon? Jack: 17 other clubs wouldn't give him an interview, but the Bombers may have backed themselves into a corner where appointing him is the only way out.01:28:53 — Merit vs Member Sentiment Rowan Connolly's question: would you take James Hird or John Longmire (five grand finals, one premiership, 60%+ win rate)? The answer is obvious on merit — but members and fans want the fairy tale.01:29:47 — Carlton's Astonishing Revival Three straight wins. Ranked 16th in forward-50 entries a month ago; now second. The game style is unrecognisable — no more bombing the ball to non-existent power forwards. Mitch McGovern's low, flat kick to Patrick Cripps for the match-winner against Geelong was emblematic of the transformation. Seven players aged 21 or younger are now getting games and bringing energy.01:33:18 — FIFA World Cup 2026: Nobody's Excited Expanded to 48 teams, Scotland are going — and a Scot in his 30s told Jack that neither he nor any of his mates (all doing well financially, normally first on the plane) have any interest. Ticket prices are "extraordinary." The final is at MetLife Stadium in New Jersey — which Jack describes as "Waverley on steroids, but even more bleak."01:36:08 — Australia's Draw Socceroos face Turkey first up, then the United States. Jack suggests marketing it as "Gallipoli Round Two." Spain are favourites; England, Brazil, and Germany are in the chasing pack.01:37:06 — Cricket: England v New Zealand, First Test at Lord's Joel runs through New Zealand's likely top seven — Latham, Conway, Williamson, Ravindra, Mitchell, Blundell — noting the first four have all made Test double-centuries. "Just about the best first six in Test cricket." With O'Rourke's express pace and Henry's quality, this is a formidable Black Caps side.01:38:40 — Stump Speech & Next Week Listener mail (including an "exposé of who Jack is") held over for next episode. For the record: Hong Kong Jack's CV includes HSC at Assumption College Kilmore, a stint as a carpenter, a law degree from Melbourne University, stints at Holding Redlich and Slater & Gordon, work as a litigation and immigration lawyer, and an appointment to the Refugee Review Tribunal as a federal cabinet appointee.01:40:39 — Outro Joel thanks listeners for hanging in for an extra ten minutes. Back next week.The Two Jacks is recorded weekly. Send your questions and feedback to the show.

Der DGB will die Betriebsrente für alle verpflichtend machen – und die Arbeitgeber sollen mindestens mit zahlen. OpenAI plant den größten Umbau von ChatGPT und will aus dem Chatbot eine Super-App für Firmenkunden machen. Und Biontech hält nach dem angekündigten Rückzug der Gründer an genau der Technologie fest, die das Unternehmen während der Pandemie weltbekannt gemacht hat: mRNA. Hinweis: In diesem Podcast verwandeln moderne KI-Systeme journalistische Inhalte, die auf unseren ntv Plattformen publiziert wurden in ein neues Hörformat. Text und Stimme der Sprecherin wurden mithilfe Künstlicher Intelligenz erzeugt. Vor der Veröffentlichung werden alle Folgen nach strengen journalistischen Standards geprüft. Viel Spaß beim Zuhören! Dieser Podcast wird vermarktet von Julep Media: sales@julep.de Wir verarbeiten im Zusammenhang mit dem Angebot unserer Podcasts Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, melden Sie sich hier: datenschutz@julep.de

Tech entrepreneur Steve Kirsch used advanced AI to analyze raw, independent datasets about mRNA injuries – and uncovered what “no public health official wants to know.” Legacy media continues to ignore the staggering reality of adverse reactions and side effects of mRNA for COVID-19. Steve Kirsch took matters into his own hands – and his latest analysis estimates that as many as 2 million Americans were seriously disabled by the shots. He joins Dr. Kelly Victory to share his methods, how he used AI to analyze the data, and why “not a single national public-health authority, anywhere in the world, has produced an estimate of the type we just constructed.” Steve Kirsch is a former Silicon Valley high-tech executive with two engineering degrees from MIT. He founded the COVID-19 Early Treatment Fund and the Vaccine Safety Research Foundation (VSRF). He hosts the VSRF Live Weekly Update and has authored more than 1,900 articles on vaccine safety at kirschsubstack.com. Follow at https://x.com/stkirsch Dr. Kelly Victory is Chief of Emergency & Disaster Medicine at The Wellness Company. A trauma and emergency specialist with over 30 years of experience, she served as Chief Medical Officer for Fortune 500 companies and is an alumna of Harvard's National Preparedness Leadership Initiative. She is a contributing author of “Toxic Shot: Facing the Dangers of the COVID Vaccines.” Find more at https://x.com/DrKellyVictory 「 SUPPORT OUR SPONSORS 」 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Hosted By • Dr. Drew Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/drdrew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

TODAY ON THE ROBERT SCOTT BELL SHOW: Trump's Vaccine Executive Order, Ebola PCR Contradictions, mRNA Ebola Funding, Processed Food Reality, Ferrum Iodatum, Ebola Platform Push, Betrayal of Religious Freedom, Expanded Access to Supplements, Organic Milk Pricing, Prayer Health Benefits, and MORE! https://robertscottbell.com/vaccine-eo-backs-hhs-story-behind-vaccine-eo-ebola-pcr-contradictions-mrna-ebola-funding-processed-food-reality-ferrum-iodatum-ebola-platform-push-betrayal-of-medical-freedom-expanded-access-t/ Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we dive into a series of groundbreaking advancements and strategic maneuvers reshaping the landscape of drug development and patient care. In recent news, Moderna and Merck & Co. have reported substantial progress in cancer treatment with their Phase 2b trial results involving Intismeran Autogene combined with Keytruda. This combination therapy, leveraging the innovative mRNA vaccine technology alongside Keytruda, has shown a remarkable 49% reduction in recurrence risk for high-risk melanoma patients. This synergy not only enhances therapeutic options in melanoma but also underscores the transformative potential of mRNA vaccines beyond infectious diseases, suggesting a new frontier for oncology treatments. Bristol Myers Squibb has also made significant strides with its Phase 3 trial results for Izalontamab Brengitecan, an antibody-drug conjugate. This therapy has demonstrated a 40% reduction in death risk among patients with triple-negative breast cancer—an aggressive subtype with historically limited treatment options. The success of this bispecific antibody targeting Trop2 highlights the advancing trend towards precision medicine, where therapies are increasingly tailored to specific genetic and molecular profiles, promising improved patient outcomes. Turning to business developments, Rallybio's merger with Avenzo Therapeutics through a reverse merger transaction marks a notable consolidation trend within the industry. Supported by a $215 million private placement, this merger aims to accelerate drug discovery and development in oncology, emphasizing the importance of strategic collaborations in enhancing therapeutic pipelines. Similarly, MindMaze Therapeutics is streamlining operations post-merger by refocusing on core competencies aligned with broader industry trends towards specialization. Regulatory updates have been equally dynamic. Shionogi's Xocova (Ensitrelvir) has received FDA approval for post-exposure prophylaxis against COVID-19 following successful Phase 3 trials. As a small-molecule protease inhibitor, Xocova enriches the therapeutic arsenal against COVID-19 and reflects ongoing efforts to manage infectious diseases even as the pandemic wanes. Strategic partnerships are further shaping the industry landscape. The collaboration between ASCO and Ryght AI aims to enhance breast cancer trial site selection using artificial intelligence. This initiative signifies a growing trend towards integrating AI and machine learning technologies in clinical trial optimization to streamline processes and improve efficiency—an essential endeavor as trials become more complex and data-driven. Additionally, Sanofi's integration of AI via field agents to enhance efficiencies across business facets highlights how AI adoption is accelerating and promises to reshape drug development processes and patient care strategies significantly. Meanwhile, challenges persist. The FDA's rejection of Cingulate's CTX-1301 due to manufacturing concerns underscores the rigorous regulatory environment that companies navigate. Similarly, Roche's Persevera trial missing its primary endpoint in breast cancer treatment highlights the inherent risks involved in drug development. In scientific advancements, Gilead Sciences has made progress with Livdelzi in treating primary biliary cholangitis (PBC), a rare liver disease. The Phase 3 trial success points to ongoing innovation in rare disease treatments—a critical area for enhancing patient outcomes. On another front, Contraline is advancing its male birth control candidate after securing $92.5 million in funding. This first-in-class topical contraceptive fills a significant gap in male contraceptive options, demonstrating an increasing focus on diversifying reproductive health solutions. In strategic shifts within the industry, Merck is reducing its workforce as part of a broader $3 billion cost-cutting strategy aimed at optimizing operations while investing in innovation and technology. At ASCO 2026, Celcuity shared ambitions to revolutionize breast cancer treatment paradigms through innovative pathway targeting, while GSK introduced a new approach for rare gut cancers—conditions that have seen little advancement over decades. Such initiatives highlight critical roles innovative research plays in oncology. In summary, these developments reflect a vibrant period for the pharmaceutical and biotech sectors characterized by scientific innovation, strategic mergers, regulatory milestones, and ongoing clinical trials that collectively promise to enhance patient care. Emphasis on personalized medicine, expansion of mRNA technology into oncology, and AI-driven efficiencies are poised to redefine approaches across therapeutic domains while navigating stringent regulatory standards and market dynamics that require strategic agility and robust R&D pipelines. Thank you for tuning into Pharma Daily—your source for insightful updates from the world of pharmaceuticals and biotechnology. Stay connected for more groundbreaking news and analysis shaping the future of healthcare.Support the show

At the American Society of Clinical Oncology (ASCO) annual meeting in Chicago this past weekend, packed plenary sessions from Revolution Medicines and Summit Therapeutics' Chinese partner Akeso stole the show. For RevMed, analysts anticipate a potential approval in pancreatic cancer as early as this year, while Summit still has a tough road ahead showing that the survival benefit seen in Akeso's clinical trial in China will hold up in a global population.Immuneering, BMS/BioNTech, Merck, Pfizer and many more also scored oncology wins at the annual meeting, as did Moderna, with “encouraging” 5-year survival for its mRNA-based personalized melanoma vaccine. Outside of ASCO, the past week saw Pfizer strike an unusual pact with China's Innovent Biologics as it seeks to bolster its oncology pipeline. Reminiscent of another recent deal from BMS and Hengrui Pharma, it could signal a more collaborative approach to working with Chinese companies. We'll also cover the latest deals from Eli Lilly, which continues to rack up partners with its GLP-1 windfall. Finally, learn about how BrainStorm is planning another FDA bid for its experimental ALS therapy NurOwn with former regulator Peter Pitts now on the board, and check out a preview of the 2026 American Diabetes Association, or ADA, which kicks off this weekend in New Orleans.

Text the Show⭐️ Affiliate item of the week: FosPower Solar Hand Crank Emergency Radio: https://amzn.to/3PLuoBf NOAA Weather Radio 19240mWh Portable Power Bank, AM/FM, USB/Solar/Hand Crank Charging, Battery Operated, SOS Alarm & Flashlight for Indoor/Outdoor Emergencies.What happens when artificial intelligence becomes the gatekeeper of truth, faith, commerce, and even human behavior? Tonight, JD Rucker joins us to explore the rise of The Algorithm and its growing influence over the Church, media, and everyday life.We dive into AI's role in information management, the future of prepping and survival in a technologically controlled world, and whether society is being guided toward a digital beast system hidden in plain sight. Is the algorithm simply a tool or is it becoming a belief system of its own? Visit JD's prepper website: The Late Prepper: https://www.lateprepper.com/ Watch the JD Rucker Show: https://jdruckershow.substack.com/JD Rucker substack: https://jdrucker.substack.com/Support the show using Buy Me A Coffee: https://buymeacoffee.com/dangerousinfopodcast SMART is the acronym that was created by technocrats that have setup the "internet of things" that will eventually enslave humanity to their needs. Support the showLeave Voicemail: https://www.speakpipe.com/DangerousInfoWebsite https://www.dangerousinfopodcast.com/Discord chatroom: https://discord.gg/8feGHQQmwgEmail the show dangerousinfopodcast@protonmail.comJoin mailing list http://bit.ly/3Kku5YtWatch LiveYouTube https://www.youtube.com/@DANGEROUSINFOPODCASTRumble https://bit.ly/4q1Mg7Z Twitch https://www.twitch.tv/dangerousinfopodcastPilled.net https://pilled.net/profile/144176  Facebook: https://www.facebook.com/DangerousInfoPodcast/SocialsInstagram https://www.instagram.com/dangerousinfo/TwitterX https://twitter.com/jaymz_jesseYouTube https://bit.ly/436VExnFacebook https://bit.ly/4gZbjVa

Die Zahl der Fälle von schwarzem Hautkrebs ist in Deutschland in den vergangenen Jahren enorm gestiegen. Jetzt hat ein Forschungsteam einen neuen mRNA-Impfstoff entwickelt. Das Besondere: Patienten bekommen maßgeschneiderte Dosierungen verabreicht. Budde, Joachim www.deutschlandfunk.de, Forschung aktuell

In this monolog, Casey talks about a 2025 report highlighting the role of SARS-CoV-2 mRNA vaccine in sensitizing cancer patients to immune checkpoint inhibitor therapy.

Guest: Dr. Samuel Nobs is an Assistant Professor and Group Leader at the Institute for Research in Biomedicine in Switzerland. He discusses how microbes in the lungs and gut may shape respiratory immunity and influence susceptibility to infections and chronic lung diseases. He highlights his lab's work to uncover the mechanisms behind these interactions using microbiome analysis and advanced experimental models. Featured Products and Resources: Download a practical guide on everything you need to know about cell isolation techniques. Download a free wallchart on the production of CAR T cells. The Immunology Science Round Up Rabbit Immunity Evolves – Wild rabbits rapidly evolved resistance to myxoma virus through changes in highly diverse MHC immune genes. Antifungal Receptors Improve Vaccines – Targeting antifungal immune receptors with a mannan-based adjuvant boosts the strength, durability, and variant coverage of mRNA vaccine responses. Mapping Tumor Macrophage Diversity – Scientists have revealed how diverse tumor-associated macrophage subtypes promote tumor growth, immune suppression, and metastasis through interactions within the tumor microenvironment. Dietary Soy Shapes Immunity – Dietary soy shapes the gut microbiome to boost IgA-mediated immunity and enhance protection against intestinal infection in early life. Image courtesy of Dr. Samuel Nobs. Subscribe to our newsletter! Never miss updates about new episodes. Subscribe

Send us Fan MailWhat happens when a well-selected constitutional remedy isn't enough?In this fascinating conversation, Vanessa & Heather interview Ton Jansen and Roger Savage and explore Ton's groundbreaking Human Chemistry approach: a system developed after decades of observing cases that failed to progress despite careful classical homeopathic prescribing.We discuss:✨ Why chronic cases can become "stuck" after years of vaccinations, antibiotics, steroids, and other suppressive influences✨ The role of homeopathic detoxification in restoring the body's ability to heal✨ Ton's approach to vaccine-related injuries and chronic childhood illness✨ Autism, allergies, autoimmune disease, and complex chronic conditions✨ Why constitutional remedies sometimes need support from detox and terrain-based approaches✨ The difference between natural immunity and vaccine-induced immunity✨ COVID vaccine detox strategies and mRNA clearing protocols✨ Potency selection, remedy timing, and why Ton never mixes potencies together✨ The importance of fever, trauma resolution, lifestyle factors, and rebuilding vitality✨ How Human Chemistry has evolved beyond "homeopathic detox" into a complete system for addressing chronic diseaseWhether you're a homeopath, holistic practitioner, or health-conscious parent, this episode offers a thought-provoking look at how modern toxic burdens and medical suppression may impact healing, and what can be done when traditional approaches no longer seem to move a case forward.

While the longevity field is filled with dubious claims and junk science, there have been some truly remarkable advances that will have an impact on how we can live longer and stay healthier. In this episode, Kara unpacks some of them with Dr. Eric Verdin, the president and CEO of the Buck Institute for Research on Aging in Novato, California. The Buck Institute was the first of its kind, and it's at the forefront of all the latest research on longevity.  Later she speaks to Dr. Vinod Balachandran, attending physician and director of The Olayan Center for Cancer Vaccines at Memorial Sloan Kettering in New York. He'll explain his research into mRNA vaccines and their potential to treat and possibly cure pancreatic cancer.  Questions? Comments? Email us at on@voxmedia.com or find us on YouTube, Instagram, TikTok, Threads, and Bluesky @onwithkaraswisher. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Truth Be Told with Booker Scott – Concerns over mRNA platforms, lab-cultured proteins, and public food programs raise urgent questions about labeling, school lunches, and local control. Calls for transparency, state action, and community accountability connect food safety debates with broader fights over professional speech, constitutional limits, and citizens' duty to defend family, faith, and freedom now...

Dr. Mary Talley Bowden, the Houston physician who sued the FDA and won, joined David Knight to give a status report on what is decidedly not over: 29 states still recommend three mRNA shots for babies by nine months old, seven million children received the latest mRNA injection this year, and 20% of Americans say their doctors are actively pushing annual boosters. Bowden — who paid for her independence with hospital privileges and a years-long professional assault — points to RFK Jr.'s silence on the shots since taking the HHS position as proof that the power game swallowed him whole, while Trump continues bragging about Warp Speed and giving commendations to the team that ran it. Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code “KNIGHT” For high quality made in America products go to HomeSteadProducts.shop and use promo code “Knight” for 10% off your purchases Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-show Or you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

Dr. Mary Talley Bowden, the Houston physician who sued the FDA and won, joined David Knight to give a status report on what is decidedly not over: 29 states still recommend three mRNA shots for babies by nine months old, seven million children received the latest mRNA injection this year, and 20% of Americans say their doctors are actively pushing annual boosters. Bowden — who paid for her independence with hospital privileges and a years-long professional assault — points to RFK Jr.'s silence on the shots since taking the HHS position as proof that the power game swallowed him whole, while Trump continues bragging about Warp Speed and giving commendations to the team that ran it. Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code “KNIGHT” For high quality made in America products go to HomeSteadProducts.shop and use promo code “Knight” for 10% off your purchases Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-show Or you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

Send us Fan MailIn this fast-paced episode of Neo News, Eli and Ben tackle the rapidly shifting landscape of vaccine regulation and economics in the US. They discuss recent political maneuvers surrounding the Vaccine Injury Compensation Program (VICP) and how expanding liability could quietly push manufacturers out of the market entirely. The hosts also examine the FDA's recent hesitation to review Moderna's new mRNA flu vaccine, highlighting how these administrative roadblocks threaten the financial viability of developing novel vaccines—including critical immunizations for pediatric and neonatal populations. Tune in for a sharp analysis of how top-down policy changes might reshape everyday clinical practice!----1) https://thehill.com/policy/healthcare/5689850-kennedy-dismisses-vaccine-advisors/2) https://www.washingtonpost.com/opinions/2026/01/15/rfk-jr-vaccines-autism-vicp/3) https://www.nytimes.com/2026/02/18/health/fda-moderna-flu-vaccine-mrna.html4) https://www.nytimes.com/2026/02/16/health/rfk-vaccine-manufacturers.htmlSupport the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

W Demokratycznej Republice Konga oraz Ugandzie trwa epidemia rzadkiego gatunku wirusa Ebola o nazwie Bundibugyo, w której przebiegu odnotowano już ponad tysiąc potwierdzonych i podejrzewanych przypadków zachorowań. Największe przeszkody w opanowaniu sytuacji stanowią brak specyficznej szczepionki przeciwko temu konkretnemu wariantowi, słaba infrastruktura medyczna oraz niestabilna sytuacja w regionie. Obecnie pomoc chorym opiera się głównie na leczeniu zachowawczym i intensywnym nawadnianiu, jednak trwają prace nad wykorzystaniem leków przeciwwirusowych oraz technologii mRNA do szybkiego opracowania nowego preparatu ochronnego.

Tim, Ian, and Brett are joined by Bradley Devlin to discuss the DOJ launching a criminal investigation into Trump accuser E. Jean Carroll for lying, Democrats are broke and disorganized, Trump say's he doesn't care about midterms, an insane conspiracy claims Massie's wife death was a deep state plot, a bombshell study reveals possible link between MRNA vaccines and dangerous heart complications, and Jill Biden admits she though Joe Biden was having a stroke during disaster debate.  SUPPORT THE SHOW BUY CAST BREW COFFEE NOW - https://castbrew.com/ Join - https://www.youtube.com/channel/UCLwN... Hosts:  Tim @Timcast (everywhere) Ian  @IanCrossland  (everywhere) | https://graphene.movie/ Brett  @PopCultureCrisis  (everywhere) Producer: Carter @carterbanks (X) |  @trashhouserecords  (YT) Guest:  Bradley Devlin @bradleydevlin (X)  Podcast available on all podcast platforms! DOJ Launches INVESTIGATION Into Trump Accuser For LYING | Timcast IRL For advertising inquiries please email sponsorships@rumble.com

Israeli citizen, Ori Solomon, was caught operating an illegal bio-lab in a Las Vegas residential neighborhood. The setup contained HIV, malaria, tuberculosis, and other hazardous biological materials while working alongside Chinese operators on U.S. soil. A Trump appointed Jewish judge just dropped all charges and allowed him to flee to Israel. Karen Kingston is back dropping nuclear red pills on the mRNA nanotechnology weapons disguised as “vaccines.” This is straight-up criminal human experimentation and bioweapon deployment on the American population – and the Deep State murderers behind it are still walking free with zero accountability.

Στο νέο επεισόδιο της σειράς «Η επιστήμη και οι επιστήμονες» της Athens Voice, ο Γιώργος Παυλάκης μιλά για τη διαδρομή του στην έρευνα, τη φύση της επιστήμης και τις μεγάλες προκλήσεις της σύγχρονης ιατρικής. Ξεκινώντας από τα παιδικά του χρόνια, περιγράφει πώς επηρεάστηκε από το όνειρο του πατέρα του να γίνει γιατρός και πώς ήδη από το δημοτικό είχε στραφεί προς τη βιοχημεία και την επιστημονική αναζήτηση. Τονίζει ότι η επιστήμη, παρά τη γοητεία της, είναι κυρίως μια διαρκής διαδικασία αποτυχιών, όπου ο ερευνητής πρέπει να μάθει να «πέφτει και να ξανασηκώνεται». Σύμφωνα με τον ίδιο, το 99% των πειραμάτων αποτυγχάνει, αλλά κάθε αποτυχία μπορεί να οδηγήσει σε νέα γνώση. Ο Παυλάκης εξηγεί πως η έρευνα απαιτεί ακραία εξειδίκευση, γεγονός που συχνά περιορίζει τη γενικότερη εικόνα, ενώ παράλληλα αναφέρεται στη χαρά της ανακάλυψης, περιγράφοντας τη στιγμή που κατάλαβε ότι ένα «αποτυχημένο» πείραμα αποκάλυπτε έναν νέο μηχανισμό ανοσοθεραπείας για τον καρκίνο. Εστιάζει ιδιαίτερα στις εξελίξεις στη θεραπεία του καρκίνου, επισημαίνοντας ότι πολλές μορφές του πλέον είτε ιάσιμες είτε μετατρέπονται σε χρόνιες παθήσεις. Ξεχωρίζει τη σημασία των νέων θεραπειών για τον καρκίνο του παγκρέατος, που βασίζονται στη στόχευση του γονιδίου RAS, αποτέλεσμα δεκαετιών ερευνών. Σημαντικό μέρος της συζήτησης αφιερώνεται στην ανοσοθεραπεία, την οποία παρουσιάζει ως μια επανάσταση σε σχέση με τη χημειοθεραπεία, καθώς αξιοποιεί το ίδιο το ανοσοποιητικό σύστημα για την καταπολέμηση του καρκίνου. Περιγράφει επίσης τη συμβολή της τεχνολογίας mRNA, τόσο στα εμβόλια κατά της Covid-19 όσο και στις μελλοντικές θεραπείες για τον καρκίνο και το AIDS. Αναφερόμενος στην πανδημία, υπογραμμίζει ότι οι Κινέζοι επιστήμονες αντέδρασαν γρήγορα δημοσιεύοντας το γενετικό υλικό του κορωνοϊού, γεγονός που επέτρεψε την ταχεία ανάπτυξη διαγνωστικών εργαλείων και εμβολίων. Παράλληλα, εκφράζει ανησυχία για το μέλλον της ανθρωπότητας απέναντι στις νέες τεχνολογίες και την τεχνητή νοημοσύνη, σημειώνοντας ότι η τεχνολογική πρόοδος δεν συνοδεύεται πάντα από ανάλογη ηθική πρόοδο. Κλείνοντας, ο Παυλάκης τονίζει ότι κάθε επιστήμονας προσπαθεί να προσθέσει «ένα μικρό βοτσαλάκι» στο οικοδόμημα της γνώσης, βασιζόμενος πάντα στο έργο των προηγούμενων γενεών και αφήνοντας παρακαταθήκη για τις επόμενες. Με την υποστήριξη των Σίμου και Ζέτας Παληού Συντελεστές Sound design, ηχοληψία: Κάκια Γκουδίνα Η ηχογράφηση έγινε στο Athens Voice Studio

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape of these industries continues to evolve with significant scientific advancements, regulatory breakthroughs, and strategic maneuvers that are reshaping drug development and patient care. One of the noteworthy developments is the U.S. FDA's recent approval of Gilead Sciences' Hepcludex (bulevirtide) for hepatitis D. This approval marks a comeback for Gilead after previous setbacks due to manufacturing and delivery issues, highlighting the critical importance of addressing regulatory feedback. It's a testament to persistence in overcoming manufacturing challenges to ensure vital therapies reach those in need. This approval signifies a milestone as it's the first FDA-approved therapy targeting chronic hepatitis D virus infection—a niche condition with limited treatment options. Similarly, Pfizer's Braftovi (encorafenib) is expanding its global reach beyond U.S. borders with regulatory approvals in the EU and Canada for colorectal cancer treatment. This broadening geographic footprint reflects a broader industry trend where companies aim to maximize the therapeutic impact of oncology drugs across diverse patient populations. Meanwhile, Astellas Pharma is navigating the looming patent cliff for its prostate cancer drug Xtandi by actively pursuing new licensing deals and implementing cost-cutting measures. This dual approach underscores a widespread industry strategy where companies balance acquisitions with operational efficiency to sustain growth. In the radiopharmaceutical sector, there's notable activity with Lantheus Holdings possibly being acquired by Curium for $7 billion. This potential deal underscores growing interest in radiopharmaceuticals due to their precision in targeting specific cancer types. Complementing this is Niowave's $75 million investment in a radiopharmaceutical isotope plant in Michigan, set to produce actinium-225 by 2028—an isotope crucial for targeted cancer therapies. Regulatory landscapes are also in flux with continued reforms at the FDA despite leadership changes. Initiatives like the Commissioner's National Priority Voucher program illustrate regulatory bodies' commitment to streamlining drug approvals and fostering innovation. On an international note, SK Bioscience is partnering with Colombia to locally produce the chickenpox vaccine Skyvaricella, enhancing vaccine accessibility through technology transfer. Similarly, Eli Lilly's acquisition spree in infectious disease research signals a robust push toward expanding its R&D pipeline for viral and bacterial pathogens. Eli Lilly has announced plans to acquire Curevo, Limmatech Biologics, and another vaccine company for up to $3.8 billion. This strategic acquisition underscores a commitment to enhancing capabilities in infectious diseases—a field that has gained focus post-COVID-19 pandemic. By integrating these companies, Eli Lilly aims to leverage their platforms and expertise for advanced therapeutic solutions against infectious diseases. In gene editing, Eli Lilly is preparing for a Phase 2 trial of a lipid-lowering gene editor from Verve Therapeutics, showing promising cholesterol reductions akin to PCSK9 inhibitors. This highlights gene editing's potential in addressing cardiovascular diseases. A significant development from Lilly's pipeline includes promising results from their base editor technology acquired through Verve Therapeutics—an exciting breakthrough suggesting substantial potential for gene-editing technologies addressing genetic disorders like high cholesterol. In oncology, AstraZeneca and Daiichi Sankyo's Datroway gained FDA approval for triple-negative breast cancer as a first-line treatment. This antibody-drug conjugate targets Trop2, demonstrating the potential of targeted therapy in difficult-to-treat cancers. Kura Oncology's combination therapy featuring darlifarnib and Krazati showed up to a 69% response rate in KRAS G12C-mutated solid tumors during Phase 1 trials, emphasizing precision medicine's potential in targeting specific genetic mutations driving cancer progression. In obesity management, Eli Lilly's retatrutide achieved Phase 3 success with bariatric surgery-like outcomes. The drug acts as a triple hormone receptor agonist, showcasing advancements in metabolic therapies targeting obesity—a condition linked with numerous comorbidities. Moderna's mFlusiva is poised for an FDA advisory committee review as an influenza preventative for older adults—an extension of Moderna's mRNA technology initially used against COVID-19. Collectively, these developments highlight an industry leveraging cutting-edge science and technology to tackle complex medical challenges. As pharmaceutical giants like Eli Lilly consolidate their positions through acquisitions and research collaborations, transformative advancements promise to reshape patient care across various therapeutic areas. These initiatives not only reflect the industry's dynamic nature but also its pivotal role in addressing unmet medical needs worldwide. Eli Lilly's recent strategic acquisitions underscore its commitment to advancing pharmaceutical innovations, particularly in vaccines and cholesterol management sectors. Acquiring three vaccine-focused biotech firms signifies substantial investment in expanding its vaccine portfolio—a move aligned with global immunization strategies. This follows hiring Peter Marks from the FDA, indicating a strategic focus on bolstering expertise within the vaccine domain. The company has been recognized by IDEA Pharma as a leader in pharmaceutical innovation—a testament to its robust pipeline and successful integration of scientific advancements into marketable therapies. Across oncology landscapes highlighted at ASCO conferences are exciting potentials like Summit Therapeutics and Akeso's potential Keytruda rivals that could reshape cancer treatment paradigms if proven effective. As pharmaceutical landscapes continue evolving rapidly through scientific strides tempered by regulatory hurdles—the current environment promises significant advancements offering new hope while demanding strategic agility within healthcare sectors globally.Support the show

Dr. Marc Siegel comes on to talk about current global health threats, primarily focusing on a modern Ebola outbreak in the Congo. The conversation highlights how war-torn regions and a lack of healthcare infrastructure accelerate the spread of disease, especially when local distrust leads to the abandonment of medical facilities. Dr. Siegel addresses the erosion of public trust in health institutions following the COVID-19 pandemic, criticizing past authoritarian messaging and outdated containment strategies while expressing hope for new mRNA vaccine technology to combat different Ebola strains. Learn more about your ad choices. Visit megaphone.fm/adchoices

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of noteworthy advancements and challenges that are shifting the landscape of drug development and patient care. Starting with AstraZeneca and Daiichi Sankyo, their Trop2-directed antibody-drug conjugate, Datroway, has secured FDA approval for first-line treatment in triple-negative breast cancer. This form of cancer is notoriously aggressive and offers limited treatment options, making this approval a significant milestone. It positions Datroway as a key player in the ADC market targeting TNBC, highlighting the increasing role of antibody-drug conjugates in oncology. This advancement not only expands therapeutic options for patients but also emphasizes the growing importance of ADCs in effectively targeting cancer cells while sparing healthy tissues. In another exciting development, Merck and Kelun Biotech have reported on their SAC-TMT ADC, which when paired with Keytruda, shows a profound impact on PD-L1-positive non-small cell lung cancer patients. Their combination therapy demonstrated a remarkable 65% reduction in disease progression or death compared to Keytruda alone. Presented at the ASCO annual meeting, these findings could potentially revolutionize first-line treatments for NSCLC, further underscoring the promising therapeutic potential of combining ADCs with immunotherapies. However, AstraZeneca faced a setback with a novel breast cancer drug as an FDA advisory committee recommended against its approval. Interestingly, the European Medicines Agency provided a favorable opinion, illustrating the divergent regulatory landscapes across continents. Such discrepancies highlight the complex regulatory environment pharmaceutical companies must navigate and could influence strategic decisions regarding market focus. On the legal front, Eli Lilly is embroiled in controversy over an alleged $200 million rebate fraud scheme involving its diabetes drug, Trulicity. This situation sheds light on ongoing issues within pharmaceutical distribution channels and raises questions about compliance and oversight mechanisms necessary to prevent such financial misconduct. Meanwhile, industry dynamics continue to evolve as AbbVie announced workforce reductions in its Allergan Aesthetics unit. This move reflects broader trends where companies streamline operations to prioritize core competencies and promising therapeutic areas. From a regulatory perspective, Maat Pharma's decision to seek re-examination for its graft-versus-host disease medication underscores the iterative nature of drug approval processes. Persistence in addressing regulatory feedback remains crucial as companies strive for successful market entry. In obesity management, Novo Nordisk's oral GLP-1 receptor agonist, Wegovy, gains traction as a convenient treatment option. The shift towards oral medications could significantly improve patient adherence and outcomes by offering an easier alternative to injections. Biogen's decision to terminate its collaboration with Denali Therapeutics after unsuccessful phase 2 trials for a Parkinson's disease candidate highlights the inherent risks in neurological drug development. Rigorous clinical evaluation remains essential to ensure efficacy before advancing therapies further. Despite these advancements, challenges persist as Biogen and Denali's BIIB122 failed in phase 2b trials for idiopathic Parkinson's disease. This underscores the complexity of neurological disorders and emphasizes the need for continued innovation targeting LRRK2 kinase inhibitors. In the realm of CAR-T therapies, Novartis' T-Charge platform faces competition from emerging in vivo technologies. This competitive landscape demonstrates rapid evolution within cell therapy domains, aiming to enhance efficacy and accessibility for patients. Meanwhile, strategic mergers and acquisitions continue as Liminatus Pharma acquires CAR-T biotech Innocsai for $320 million, underscoring sustained interest in oncology cell therapies. Switching gears to Eli Lilly's recent Phase 3 TRIUMPH-1 trial results for retatrutide, they reveal promising weight loss outcomes comparable to bariatric surgery. As a triple hormone receptor agonist targeting GLP-1, retatrutide holds significant potential in addressing obesity—a condition with profound public health implications. Medtronic's acquisition of SPR Therapeutics to enhance its chronic pain portfolio reflects a focus on minimally invasive treatments. Financially, Research Alliance III raised $75 million through a SPAC IPO targeting mergers with China-based biotech firms, signaling increased global collaboration within the sector. Dandelion Health's $14 million Series A funding aims to advance clinical intelligence platforms that could transform drug development through data analytics. Finally, Moderna's mRNA-based flu vaccine is set for review by the FDA's vaccine advisory committee after overcoming initial regulatory hurdles. This scrutiny highlights ongoing challenges faced by novel vaccine technologies within rigorous regulatory environments. In summary, these developments illustrate an industry at the forefront of scientific innovation while grappling with regulatory complexities and operational challenges. From antibody-drug conjugates and immunotherapy combinations to gene editing and advanced cell therapies, there's a clear commitment to improving patient outcomes through novel scientific approaches. As these trends evolve, they promise to redefine treatment landscapes across various therapeutic areas—offering new opportunities for scientific advancements and enhanced patient care worldwide.Support the show

America Out Loud PULSE with Dr. Peter McCullough and Malcolm Out Loud – If SV40 is many times above the safety level in the covid shots, do you think we will get cancer? Are vaccinated sperm still contaminated with mRNA 5 years after the vaccine? If these side effects are cumulative, why has nothing happened yet? What can be done to ensure I don't have to be on these supplements forever?

A stunning Fox News poll reveals only 31% of Americans believe the Trump assassination attempt was definitely real, sparking a deep dive into media distrust, AI manipulation, and political division. Tara and Lee expose growing concerns over Chinese influence in American politics, climate narratives unraveling, mRNA vaccine fears, and the Democrat Party's collapsing support among men. Plus: Iran tensions, censorship revelations tied to the Biden administration, and why some believe America is approaching a dangerous cultural breaking point. PODCAST SUMMARY Today's show unpacks what Tara calls “America's reality crisis” after polling shows a shockingly low number of Americans fully believe the Trump assassination attempt actually happened. The conversation explores collapsing trust in media, AI-driven misinformation fears, and the impact of hyper-partisan politics on public perception. The show then pivots to allegations of growing Chinese Communist Party influence inside the United States, including claims involving Democrat fundraising networks, activist organizations, and congressional politics. Tara and Lee also revisit the climate change debate following discussion around recent IPCC reporting and decades of controversial environmental predictions. Additional segments cover concerns surrounding mRNA vaccine development, censorship tied to COVID-era narratives, and accusations that media institutions suppressed dissenting voices. The hour closes with a look at Democrat approval ratings among male voters and the broader cultural divide shaping the 2026 political landscape. SEGMENT HIGHLIGHTS Reality Crisis in America Only 31% of Americans say the Trump assassination attempt “definitely happened” Discussion on media distrust and AI-generated misinformation Debate over conspiracy culture and social media influence China's Expanding Influence Claims of Chinese Communist Party infiltration into American politics Discussion of activist funding and alleged influence operations Concerns over China's role in shaping U.S. policy and energy dependence Climate Narrative Under Fire Hosts react to reports questioning “extreme warming pathways” Criticism of decades of climate predictions and energy policy Discussion of nuclear energy, infrastructure, and China's rise COVID, mRNA & Censorship Renewed skepticism over vaccine narratives and media suppression Discussion of Alex Berenson's legal victory and censorship claims Concerns about future virus outbreaks and public trust Democrats Losing Male Voters New polling shows collapsing approval among men Discussion of shifting political demographics Debate over whether the Democrat Party can reverse the trend KEY QUOTES “How do you hold together an America where only thirty-one percent can figure out what reality is?” “The Chinese Communist Party is the single biggest threat to this country.” “They don't need the climate lie anymore because China already won.” “Trust in media has completely collapsed.” SEO KEYWORDS Trump assassination poll, China influence America, climate change debate, IPCC controversy, Democrat approval men, AI misinformation, COVID censorship, mRNA vaccines, Trump news podcast, political commentary, American media distrust, China and Democrats, Iran tensions, Alex Berenson lawsuit, conservative podcast HASHTAGS #Trump #China #ClimateChange #Politics #Media #AI #COVID19 #Podcast #America #Democrats #Republicans #News #PoliticalPodcast #FreeSpeech #AmpersandWave

Explosive allegations rock the political world as gubernatorial candidate Ram Reddy fires back against accusations from allies of Ralph Norman, while conservatives warn about rising extremism, China's growing influence inside America, and GOP civil war tensions in Washington. From assassination attempt conspiracy theories to climate change backlash and Senate Republican infighting, today's episode covers the political chaos shaping 2026. PODCAST SUMMARY Today on AmperWave Daily, the hosts dive into a fiery interview with South Carolina gubernatorial candidate Ram Reddy, who forcefully rejects claims that he is a political “plant” for South Carolina House Speaker Murrell Smith. Reddy accuses supporters of Ralph Norman of spreading false attacks while portraying himself as an outsider willing to “throw a grenade into the swamp.” The conversation expands into broader political warfare, touching on accusations of anti-Trump sentiment among establishment Republicans, disputes over redistricting, campaign financing, and growing voter distrust in career politicians. Hosts discuss internal GOP battles involving Senate Republicans, including criticism aimed at John Thune and John Cornyn over their relationship with President Donald Trump and the America First movement. The episode also explores controversial rhetoric surrounding antisemitism, political extremism, and radical statements allegedly made by Democratic candidates. The hosts argue that Democrat leadership has failed to decisively condemn inflammatory behavior within its own ranks, while warning that ideological radicalization is accelerating nationwide. In another major segment, the show examines public distrust in media after polling showed many Americans questioning whether the attempted assassination of President Trump was real. Hosts blame declining trust in traditional media, AI-generated misinformation, and online conspiracy culture for America's fractured perception of reality. The discussion later pivots to China's influence in U.S. politics and economics. The hosts claim the China and the Chinese Communist Party have strategically benefited from climate change policies, energy restrictions, and left-wing activist networks in America. They also criticize establishment Democrats for alleged ties to Chinese-linked organizations and warn about long-term geopolitical consequences. Finally, the podcast tackles renewed fears surrounding pandemics, mRNA vaccine controversies, and media narratives around emerging viruses. Hosts express skepticism toward pharmaceutical companies, government censorship, and public health institutions while reflecting on the lingering fallout from the COVID era. KEY TALKING POINTS Ram Reddy denies claims he is connected to Murrell Smith Sharp attacks exchanged between allies of Reddy and Ralph Norman Debate over Republican establishment vs. America First conservatives Hosts criticize Senate Republicans including John Thune and John Cornyn Discussion about antisemitism and extremist rhetoric in modern politics Concerns over conspiracy theories surrounding the Trump assassination attempt Media trust collapse and AI misinformation fears Claims of growing Chinese influence inside American political and activist networks Criticism of climate change policy and energy infrastructure decisions Vaccine skepticism and pandemic-era censorship controversies SEO KEYWORDS Trump assassination attempt, Ram Reddy governor race, Ralph Norman controversy, South Carolina politics, China influence in America, Democrat extremism, GOP civil war, John Thune criticism, John Cornyn backlash, climate change debate, vaccine controversy, media trust collapse, America First movement, conservative podcast, AmperWave Daily HASHTAGS #Trump #SouthCarolinaPolitics #RamReddy #RalphNorman #China #AmericaFirst #Politics #ConservativeNews #Podcast #BreakingNews #MediaBias #GOP #ClimateChange #VaccineDebate #AmperWave FIRST COMMENT HASHTAGS #Trump2026 #SCPolitics #Br ...

Something bigger than a single vaccine debate is unfolding inside America’s public health system. In this episode of The Health Advocates, Steven Newmark explores the growing tension surrounding vaccine policy, scientific transparency, and public trust. From the FDA’s decision not to review a new mRNA flu vaccine application to reports of delayed vaccine safety studies and shifting federal recommendations, the episode connects a series of recent developments that together point to a broader transformation inside federal health agencies. The conversation examines why some officials argue these changes are restoring scientific rigor, while many scientists and public health advocates worry they are creating confusion and weakening confidence in vaccines. Most importantly, the episode focuses on what this means for patients trying to navigate healthcare decisions in an increasingly uncertain environment. Contact Our HostSteven Newmark, Chief of Policy at GHLF: snewmark@ghlf.orgA podcast episode produced by Amelia Violet Prouse, Associate Podcast & Video Producer at GHLF.We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.orgListen to all episodes of The Health Advocates on our website or on your favorite podcast channel. See omnystudio.com/listener for privacy information.

In this episode, Dr. Paloma Giangrande, Editor-in-Chief of Molecular Therapy Nucleic Acids, speaks with Normand Allaire, Head of Genomics at the Cystic Fibrosis Foundation Therapeutics Lab. They discuss the article, Upregulation of a CFTR mRNA isoform has therapeutic potential for the treatment of 3’ CFTR PTC variants, which introduces an ASO-based therapeutic approach to cystic fibrosis for the 10% of patients who lack an approved treatment. Music: 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.auShow your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

America Out Loud PULSE with Dr. Peter McCullough and Malcolm Out Loud – If SV40 is many times above the safety level in the covid shots, do you think we will get cancer? Are vaccinated sperm still contaminated with mRNA 5 years after the vaccine? If these side effects are cumulative, why has nothing happened yet? What can be done to ensure I don't have to be on these supplements forever?

The media is working overtime to manufacture the next viral panic, and pharma companies are making big money from the fear campaign. After confirming they were already working on a Hantavirus mRNA vaccine before the cruise ship outbreak – and also developing mRNA vax for ebola – Moderna's stock jumped 20%. What an odd coincidence… Diagnostic pathologist Dr. Clare Craig joins Dr. Drew to expose the suspicious timing behind the latest virus hysteria and what the pharmaceutical industry might be planning next – monkeypox, ebola, bird flu, or worse. Eric Bolling breaks down the economic warning signs flashing across the country as diesel prices near all-time highs. CA Lt. Gov. candidate Gloria Romero (running with Steve Hilton) exposes a new plot by California Democrats to repeal the “Top 2” primary system and change the rules of the election to maintain power. Dr. Clare Craig, BM BCh FRCPath, is a Diagnostic Pathologist and author of “Expired: Covid the Untold Story.” She practiced in the NHS for 15 years and became a Fellow of the Royal College of Pathologists. She was the day-to-day pathology lead for the cancer arm of the 100,000 Genomes Project and led R&D at Genomics England. She is Co-Chair of the Health Advisory and Recovery Team (HART Group). Follow at https://x.com/ClareCraigPath Eric Bolling is a TV personality, political commentator, and author. He is the host of TheEDGE and a former co-host of Fox News' The Five. A former commodities trader at the New York Mercantile Exchange specializing in crude oil, gold, and agricultural commodities, he also served on the NYMEX Board of Directors. He is a 2-time NYT bestselling author. Follow at https://x.com/ericbolling Gloria Romero is a candidate for California Lieutenant Governor, running alongside Steve Hilton. A former California State Senate Majority Leader, she was elected to the State Assembly in 1998 and the Senate in 2001. She left the Democratic Party in September 2024 and joined the Republican Party. She is also a professor, educator, and businesswoman. Learn more at https://gloriaromero.com 「 SUPPORT OUR SPONSORS 」 • COVEPURE – Do you know what's in your tap water? Get $250 off your purifier at https://covepure.com/DREW ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠• FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Hosted By • Dr. Drew Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/drdrew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Barbara Loe Fisher is the president of the National Vaccine Information Center (NVIC), a non-profit charity she co-founded with parents of DPT vaccine injured children in 1982. NVIC is a national, grassroots movement and public information campaign to institute vaccine safety reforms and informed consent protections in the public health system. Many want to put COVID-19 in the dust bin of history. However, it's critical for as much information to come out as possible because as we saw during the COVID pandemic, our government became very authoritarian in forcing shots on so many individuals. This experience has brought many to a new level of distrust and skepticism as it relates to vaccinations and the increased use of mRNA technology. Recently a former senior advisor to Dr. Anthony Fauci was indicted regarding his alleged efforts to hide records about the origins of COVID-19. Also, James Erdman III, a whistleblower from the CIA, appeared before the Senate Homeland Security Committee with testimony of an alleged coverup by Dr. Fauci and the Intelligence Community. Meanwhile, there have been concerns expressed over new pandemics (Ebola and Hantavirus) and the development of new mRNA shots. When it comes to vaccinations, there is a growing grassroots effort calling for informed consent. Sadly, Florida legislators just killed such a measure in special session. Also, some states are actively taking action to remove any exemptions from vaccinations. Additionally, Barbara noted the significant administrative changes at the FDA and the CDC, the prevalence of spike proteins related to vaccinated mothers and concerns regarding blood transfusions.

Mark Cuban joins Rav Arora on The Illusion of Consensus for a wide-ranging debate on DEI, wokeness, corporate hiring, race-based diversity goals, merit, quotas, and the backlash against progressive workplace policies. The billionaire entrepreneur, Shark Tank investor, Dallas Mavericks minority owner, and Cost Plus Drugs co-founder argues that businesses should cast a wider net for talent while still hiring the most qualified person, as Rav challenges whether corporate diversity pledges after George Floyd and Black Lives Matter became virtue signalling or a form of discrimination. They discuss EEOC data, Starbucks, Nike, JPMorgan, Pfizer, Microsoft, United Airlines, HBCUs, minority representation, universities, DEI departments, activists such as Ibram X. Kendi and Robin DiAngelo, and the Trump administration's push to dismantle DEI programmes. The conversation also revisits their previous disagreement over Covid mandates, mRNA vaccine side effects, public health ethics, Joe Rogan, pandemic policy, and whether the response to Covid created lasting mistrust in institutions. Cuban and Arora cover how business leaders navigate culture war pressure, shareholder interests, free speech, corporate virtue signalling, political polarisation, independent media, and the future of race, merit, and fairness in American companies. Subscribe to Rav's Substack for exclusive content: https://www.illusionconsensus.com/ 0:00 - Intro 02:29 — The Clash Begins 04:04 — Mark Cuban Defines DEI His Way 05:52 — “That's Not What DEI Means!” 08:29 — Are Racial Quotas Real? 12:47 — Corporate Virtue Signalling Exposed 21:13 — Should Race Ever Matter in Hiring? 29:34 — Diversity vs. Meritocracy 48:04 — Do Companies Really Even Follow DEI? 57:42 — Does DEI Actually Work? 01:21:31 — Race-Based Goals vs Pure Merit-Based Hiring 01:36:45 — Final Thoughts and Common Ground 01:38:39 — Arora challenges Cuban on campus censorship 01:41:24 — Cuban on discrimination from both political sides 01:42:59 — Why Cuban required Mavericks staff vaccinations 01:43:57 — Arora disputes community benefit of mandates 01:52:57 — Cuban's “herd immunity in three months” argument 02:05:02 — FDA internal disagreements over vaccine approval 02:05:31 — White House pressure and military mandates 02:25:00 — Comparing Covid and vaccine-induced myocarditis 02:36:23 — Infection fatality rate and serious adverse events

TODAY ON THE ROBERT SCOTT BELL SHOW: Trump PFAS Rollback, Bob Mitchell and Jacob Mazon, Avodah Naturals, PFAS Detox, Acid Reflux Options, Medicine By Captivity, Moderna mRNA Ebola Vaccine, Baric Synthetic Viruses, Kids Vegetable Secret, Epigea Repens, and MORE! https://robertscottbell.com/trump-proposes-pfas-rollback-bob-mitchell-and-jacob-mazon-question-about-acid-reflux-healing-insurance-physician-hostage-rise-moderna-develops-vaccine-before-emergency-declared-baric-synthetic-vi/ Purpose and Character The use of copyrighted material on the website is for non-commercial, educational purposes, and is intended to provide benefit to the public through information, critique, teaching, scholarship, or research. Nature of Copyrighted Material Weensure that the copyrighted material used is for supplementary and illustrative purposes and that it contributes significantly to the user's understanding of the content in a non-detrimental way to the commercial value of the original content. Amount and Substantiality Our website uses only the necessary amount of copyrighted material to achieve the intended purpose and does not substitute for the original market of the copyrighted works. Effect on Market Value The use of copyrighted material on our website does not in any way diminish or affect the market value of the original work. We believe that our use constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the U.S. Copyright Law. If you believe that any content on the website violates your copyright, please contact us providing the necessary information, and we will take appropriate action to address your concern.

Barbara Loe Fisher is the president of the National Vaccine Information Center (NVIC), a non-profit charity she co-founded with parents of DPT vaccine injured children in 1982. NVIC is a national, grassroots movement and public information campaign to institute vaccine safety reforms and informed consent protections in the public health system. Many want to put COVID-19 in the dust bin of history. However, it's critical for as much information to come out as possible because as we saw during the COVID pandemic, our government became very authoritarian in forcing shots on so many individuals. This experience has brought many to a new level of distrust and skepticism as it relates to vaccinations and the increased use of mRNA technology. Recently a former senior advisor to Dr. Anthony Fauci was indicted regarding his alleged efforts to hide records about the origins of COVID-19. Also, James Erdman III, a whistleblower from the CIA, appeared before the Senate Homeland Security Committee with testimony of an alleged coverup by Dr. Fauci and the Intelligence Community. Meanwhile, there have been concerns expressed over new pandemics (Ebola and Hantavirus) and the development of new mRNA shots. When it comes to vaccinations, there is a growing grassroots effort calling for informed consent. Sadly, Florida legislators just killed such a measure in special session. Also, some states are actively taking action to remove any exemptions from vaccinations. Additionally, Barbara noted the significant administrative changes at the FDA and the CDC, the prevalence of spike proteins related to vaccinated mothers and concerns regarding blood transfusions.

Table of Contents: Walmart Just Patented New Big Brother SURVEILLANCE – And People Are Angry About It Part 1: Something sinister is going on at Walmart Part 2: The demonic Walmart situation just went to another level Lubricant Industry Insider for a top 3 lubricant blender in the USA–Approximately 40% of global GTL Group 3 base oil production is offline as of 3 weeks ago due to the ongoing situation in the Middle East–This is a critical component of almost every modern motor oil, transmission fluid, PSF fluid, industrial lubricant, etc on the market Shell CEO sends blunt message on oil and the economy Mobil Oil Corporation and Royal Shell Oil Corporation have told COSTCO and WALMART they “have no more pre-packaged oil product to ship to them–Expect bare shelves in the automotive oil section when present inventory runs out.” Toyota Service Bulletin Warns of Looming Motor Oil Shortage Local Independent US Car Repair Shops Are Shutting Down EVERYWHERE – Here’s Why OWN AN OLDER CAR OR TRUCK? You Need to Watch THIS–The EPA is increasing the allowable ethanol gas percentage for cars and trucks in gasoline to 15%, which could affect your vintage vehicles. Stay tuned for crucial car maintenance tips regarding this new e15 gas US Auto Part Stores Are Closing EVERYWHERE — Here's Why THEY ARE KILLING OUR PETS — AND IT COULD BE SPREADING TO YOU! The USDA quietly approved Nobivac NXT — America's first self-amplifying mRNA vaccine for dogs and cats (rabies, feline leukemia, canine flu)–Vets across the country are injecting it…and most owners have NO IDEA–1000+ pages of USDA FOIA documents expose the horror: DEATHS CARDIAC ARREST NEUROLOGICAL DAMAGE STRANGE MASSES & TUMORS — often within HOURS of the shot! This self-replicating mRNA can shed through bodily secretions… meaning your pet could be turning YOU into an unwitting vaccine recipient! The farmed fish you eat are routinely sedated and mass vaccinated using over 50 different vaccines–HUNDREDS of MILLIONS of salmon, trout, and sea bass are injected with automated vaccination machines or immersed in vaccine baths every year & mRNA versions are coming soon! Tick Pandemic Has Begun in the USA! Following Bill Gates’ release of genetically modified mosquitoes, engineered ticks are now being introduced into the environment–These ticks are latching onto animals across all 50 states and affecting nearly every species around! GMO Bill Gates Ticks ‘We're In for a BAD Year': Scientists Warn of Explosion in Lyme Disease, Tick-borne Illnesses THEIR SATANIC PLAN REVEALED NANOTECH IN VACCINES PDF: Emergency Freedom Alerts 5-18-26 Click Here To Play The Part 2 Audio Source

Description: "When joint pain is present, the diagnosis of psoriatic arthritis needs to be made as soon as possible, ideally within six months to limit joint inflammation" Dr. Vinod Chandran mentions as he discusses efforts to identify a diagnostic test for those at risk of developing psoriatic arthritis.          Join host Jeff Brown as he speaks with leading rheumatologist and clinician scientist Dr. Vinod Chandran, Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto to learn more about the progress and promising results towards developing a psoriatic arthritis diagnostic test through multi-omic assays and identifying the distinct differences between psoriasis and psoriatic arthritis.  This episode provides an update on the progress to date of the NPF PsA Diagnostic Test grant initiative which has shown promising results with a potential test entering prospective study in multiple sites soon.   Thank you to Johnson and Johnson for their support of this program activity. Timestamps: (0:00)          Intro to Psoriasis Uncovered & guest welcome rheumatologist Dr. Vinod Chandran.    (0:52)          It is challenging to diagnose psoriatic arthritis with many factors leading to a delay in diagnosis. (4:56)          The start of Dr. Chandran's involvement with the PsA Diagnostic Test Grant project.   (7:55)          The different types of omics and the definition of multi-omic. (9:57)          How the multi-omic approach is used to find biomarkers relative to a specific disease pattern. (11:08)        Development of a predictive or prevention-based test using gene expression.      (13:46)        First year results identify 200 markers across different omic approaches that distinguish psoriatic arthritis from psoriasis.    (14:58)        The significance of MRNA vs mIcroRNA's use in development of a diagnostic test and how critical that is to dissemination of a                     potential test. (17:08)        Identifying the skin-joint axis in relation to different types of arthritis. (20:20)        Next steps to moving the diagnostic test research forward as a prospective study in multiple sites and the cost effectiveness of                  delivering the test.   (23:13)        If you have psoriasis, musculoskeletal, back, and joint pain think of psoriatic arthritis and be diagnosed early to maintain a good                 quality of life. Key Takeaways: ·       Given challenges associated with diagnosing psoriatic arthritis and the impact on quality of life, in 2019 NPF launched the PsA Diagnostic Test Grant project with the goal of developing an early stage test that would identify and diagnose those with psoriatic arthritis before debilitating  joint damage begins.   ·       Progress towards a PsA Diagnostic Test includes the study of multi-omic data sets where 200 distinct biomarkers have been identified leading to a greater understanding of the different pathways between psoriatic arthritis, psoriasis, and the skin joint axis.  ·       A potential diagnostic test is now moving towards the prospective study phase. Until the test is available and if joint pain is present and you have psoriasis, ask your health care provider if it could be psoriatic arthritis and treat appropriately.  Guest Bio: Vinod Chandran, MBBS, MD, DM, PhD is a rheumatologist, clinician scientist, and Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto where he is also a Professor of Medicine. His specialties include internal medicine, immunology, rheumatology, and genetic epidemiology. His research focus is on the development of biomarker-based strategies to improve early diagnosis and prognosis of psoriasis and psoriatic arthritis, identification of new treatment targets especially for those who do not respond to current therapies, and strategies to reduce the impact of disease. Dr. Chandran is a Co-Vice President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis or GRAPPA. He is an active collaborator in a multi-center research consortia such as the International Psoriasis and Arthritis Research Team and the Spondyloarthritis Research Consortium of Canada. Dr. Chandran is the recipient of research funding from the National Psoriasis Foundation for his work in identifying a "Multi-omic Diagnostic Test for PsA in Psoriasis Patients". Resources: "Understanding the NPF Psoriatic Arthritis Diagnostic Test Grant Outcomes" Advance Online. February 18, 2026.  "Managing Chronic Pain with Psoriatic Arthritis" Psoriasis Uncovered podcast episode with physiatrist Dr. Erin Maslowski, LB Herbert who lives with psoriatic disease, and moderator Susan McClelland-Tobert, a retired pediatric cardiologist who also lives with psoriatic disease. Glossary of terms: mRNA: Messenger RNA carries protein information or instructions from the DNA in a cell's nucleus to the cell's interior where the sequence is read and translated into corresponding amino acids for growing protein chains. Micro-RNA (miRNA):  Micro-RNA act as the regulator. They are short and bind to specific target mRNA's to degrade or inhibit production of protein. 

As cancer vaccines move into Phase II and III clinical trials, it isincreasingly important for surgeons to understand their role in thisevolving landscape. What exactly are these vaccines, how do they work,and what should the surgical community know about theirimplementation? Join BTK surgical education fellows Kara Button andMichelle LaBella as they sit down with Professor Robert Jones to breakdown the science of mRNA vaccines, the logistics of tissueprocurement, and the future of cancer care.Hosts:- Professor Robert Jones: Consultant Liver Surgeon, Liverpool UniversityHospitals; UK National Institute for Healthcare Research, Co-Lead forthe Cancer Vaccine Innovation Pathway, Bowel Cancer UK and RoyalCollege of Surgeons UK Lead for Research into Advanced Bowel Cancer,and UK Chief Investigator for the BNT122-01 trial.https://www.linkedin.com/in/robert-jones-6103722a/- Kara Button, DO: General Surgery Resident, Maine Medical Center;Behind the Knife Surgical Education Fellow.- Michelle LaBella, MD: General Surgery Resident; University of NorthCarolina; Behind the Knife Surgical Education Fellow.References:https://clinicaltrials.biontech.com/trials/BNT122-01Jones RP, Lee LYW, Corrie PG, et al. Individualized cancer vaccinesversus surveillance after adjuvant chemotherapy for surgicallyresected high-risk stage 2 and stage 3 colorectal cancer: protocol fora randomized trial. BJS. 2023;110(12):1883-1884.doi:10.1093/bjs/znad332https://pubmed.ncbi.nlm.nih.gov/37856683/Tie J, Wang Y, Loree JM, et al. Circulating tumor DNA-guided adjuvanttherapy in locally advanced colon cancer: the randomized phase 2/3DYNAMIC-III trial. Nat Med. 2025;31(12):4291-4300.doi:10.1038/s41591-025-04030-whttps://pubmed.ncbi.nlm.nih.gov/41115959/Rojas LA, Sethna Z, Soares KC, et al. Personalized RNA neoantigenvaccines stimulate T cells in pancreatic cancer. Nature.2023;618(7963):144-150. doi:10.1038/s41586-023-06063-yhttps://pubmed.ncbi.nlm.nih.gov/37165196/https://www.cancer.ox.ac.uk/research/lynchvax#:~:text=The%20LynchVax%20program%2C%20funded%20by,individuals%20with%20this%20genetic%20conditionPlease visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

TWiV explains mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines, and how toll-like receptor 7 alters the maternal immune landscape during influenza A infection to increase maternal and fetal morbidity, Hosts: Vincent Racaniello, Rich Condit, and Kathy Spindler Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Positions in Rosenfeld Lab (email) RFK Jr. driving vast inquiry into vaccines (NY Times) Indiana plant biologist locked out of lab by school (Science) Trump cuts CDC role in PEPFAR (Science) Ralph Baric retires (The Assembly) Baric to fight NIH funding ban (Science) Ebola outbreak in DRC (npr) Persistence of Andes virus RNA in human semen (Viruses) mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines (Cell Rep) Science will break your heart (TWiV 920) TLR7 and maternal and fetal morbidity during influenza (Sci Adv) Letters read  on TWiV 1323 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Kathy – Bloomberg Connects app and What's in Bloom  Peony Season 2026 Bloom Tracker Rich – Medpage Today: What you need to know about hantavirus Vincent – Apollo 11 Almost Never Left the Moon Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

In his weekly clinical update, Daniel Griffin and Vincent Racaniello reviewed the latest developments surrounding the hantavirus outbreak, including new interim guidance from the Centers for Disease Control and Prevention for the management of infectious cases, whether the CDC may be downplaying the significance of the outbreak because of public backlash following the COVID-19 pandemic, before Dr. Griffin deep dives into the measles outbreak, recent statistics RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, benefit of maternal vaccination against RSV for infants, efficacy and safety of a mRNA influenza vaccine  how to access and pay for Paxlovid, where to go for answers about long COVID-19, multisystem inflammatory syndrome in children and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Interim Guidance for Public Health Assessment and Management of People with Potential Exposure to Andes Virus Outbreak (CDC) Hantavirus in humans: a review of clinical aspects and management (LANCET: Infectious Diseases) "Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina (NEJM) Person-to-Person Transmission of Andes Virus in Hantavirus Pulmonary Syndrome, Argentina, 2014 (CDC: Emerging Infectious Diseases) Hantavirus on board with Prof. Vincent Racaniello (microbeTV) Transcript – Updateon CDC's Hantavirus Response 5/13/2026 (CDC) CDC Is Walking a Tightrope With Its Response to Hantavirus (Wall Street Journal) What Happened on the Hantavirus Cruise, According to a Doctor On Board (The Atlantic) Andes hantavirus outbreak on a cruise ship – an ESCMID Emerging Infections Subcommittee (EIS) rapid assessment (CMI: Clinical Microbiology and Infection) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Big outbreak, bright lights…Measles Dashboard(South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) FDA vaccine advisers recommend adding subclade K to fall shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults (NEJM) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial (Pediatrics) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Life lost due to the COVID-19 pandemic: A model-based cohort analysis of mortality displacement in the registered population of England (PLoS One) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts (NEJM) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1322 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Alan's Soap https://AlansSoaps.com/Todd Honor John's memory and the legacy he created for Ian and Alan with Alan's Artisan Soaps “John's Favorites” bundle.  Get one bar of each of his favorites for only $28.99. Bulwark Capital https://KnowYourRiskPodcast.comRegister now for the FREE “Impact of Energy" live webinar May 21st at 3:30pm Pacific.Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bonefrog https://BonefrogCoffee.com/ToddGet the new limited release, The Sisterhood, created to honor the extraordinary women behind the heroes. Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeEpisode links:Bill Gates says the merging of biometric digital ID, bank accounts and payment systems is needed to safely monitor people's health records, keeping tabs on farmers, and tackling "climate problems." Farmers are sounding the alarm — and nobody's listening. American farmer, Julius Ray Tucker, just tested his soil & found 5X more aluminum than last year. His GMO seeds grow perfectly, but his heirloom crops are dying.   5th generation cattle rancher, Braden Jensen, sounds the alarm: When Big Food Buys Out Small Farms. - Small farm gets bought out. - Within 1 year 10 more vaccines were being used on the animals. -Pigs became ill & died from mRNA vaccines. - mRNA residue being found in the meat. Now, it is more important than ever to buy from local & regenerative farms. “WE'RE DONE PRETENDING THIS IS NORMAL” Vani Hari Just Slammed Trump on Behalf of MAHA, Says the Administration is Protecting Bayer/Monsanto: “You cannot tell Americans to eat “real food”  while protecting the cancer-causing chemicals sprayed on it. Why Did California Destroy 32,000 Citrus Plants for a Bug Found Five Miles Away Two Years Ago? Thomas Massie: “They're trying to get immunity for data centers, for pesticides.” - “They're trying to get all kinds of immunity and prevent jury trials.” - “This is something that's not even on people's radar.” - “We got it struck from the Farm Bill.” - “They were trying to put immunity for glyphosate in there.” OWEN: Carbon Capture and Sequestration is a Fraud Being Perpetrated on the United States of America and ESPECIALLY the People of Louisiana - October 15th, 2024 Chuck Owen - TheHayride.com 

Hard to detect and almost impossible to treat, pancreatic cancer has long been one of medicine's most ruthless killers. For decades, it's been the cancer that science couldn't crack. But that might be starting to change. Recently, cancer researchers have announced a series of breakthroughs that, taken together, sound almost too good to be true: a drug that targets the “undruggable” gene behind most pancreatic tumors, a personalized mRNA vaccine that teaches the immune system to recognize pancreatic cancer as an enemy, and, now, an AI program that can spot the elusive disease years before doctors typically find it. So is this breakthrough a real turning point? Or another case of medical hype outrunning reality? On today's episode, Dr. Ajit Goenka of the Mayo Clinic joins Derek to walk through the science behind the latest advances in cancer detection and what they could mean for the future of health care. They discuss Dr. Goenka's new research using artificial intelligence to detect pancreatic cancer earlier than ever before … and whether machines might soon see what doctors can't. Subscribe to our YouTube channel here: https://www.youtube.com/@PlainEnglishwithDerekThompson If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guest: Dr. Ajit Goenka Producer: Devon Baroldi Additional Production Support: Ben Glicksman Learn more about your ad choices. Visit podcastchoices.com/adchoices